Skip to main content
Livermore
Livermore
ZHEN

Centessa Pharmaceuticals plc

CNTADelisted Jun 24, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001847903

Centessa Pharmaceuticals plc was delisted on Jun 24, 2026; its insiders filed their last Form 4 on Jun 24, 2026; 161 institutions reported holding it in 13F filings for Q1 2026, worth $5.90B in total; Maverick Capital was the only superinvestor holding it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Centessa Pharmaceuticals plc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Centessa Pharmaceuticals plc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Centessa Pharmaceuticals plc
NameTitleLast reported holdingLast filingFilings, past year
Medicxi Growth I LP10% Owner0IndirectJun 24, 20261
Medicxi Growth Co-Invest I LP10% Owner0IndirectJun 24, 20261
Medicxi Ventures Management (Jersey) Ltd10% Owner0IndirectJun 24, 20261
Medicxi Growth I GP Ltd10% Owner0IndirectJun 24, 20261
Medicxi Ventures I GP Ltd10% Owner0IndirectJun 24, 20261
Medicxi Ventures I LP10% Owner0IndirectJun 24, 20261
Medicxi Co-Invest I LP10% Owner0IndirectJun 24, 20261
Medicxi Secondary I LP10% Owner0IndirectJun 24, 20261
Medicxi Secondary I GP Ltd.10% Owner0IndirectJun 24, 20261
Medicxi Secondary Co-Invest I LP10% Owner0IndirectJun 24, 20261
Index Ventures Life VI (Jersey) L.P.10% Owner0IndirectJun 24, 20261
Yucca (Jersey) SLP10% Owner0IndirectJun 24, 20261
Index Venture Life Associates VI Ltd10% Owner0IndirectJun 24, 20261
Hedley Mary LynneDirector–Jun 24, 20261
Zbar Brett I WDirector–Jun 24, 20261
Weinhoff Gregory MChief Business Officer0Jun 24, 20264
Crowley John JChief Financial Officer0Jun 24, 20262
De Rubertis FrancescoDirector0IndirectJun 24, 20261
Kanes StephenChief Medical Officer0Jun 24, 20262
Kulkarni SamarthDirector–Jun 24, 20261
Anderson Karen M.Chief People Officer0Jun 24, 20265
Goyal ArjunDirector0IndirectJun 24, 20261
Hussain Iqbal JChief Legal Officer0IndirectJun 24, 20264
Stuckley CarolDirector–Jun 24, 20261
Bush Tia LChief Technology & Quality Ofc0Jun 24, 20264
Hukkelhoven MathiasDirector–Jun 24, 20261
Deferiere RaphaelChief Accounting Officer0Jun 24, 20262
Accardi Mario AlbertoChief Executive Officer0Jun 24, 20267
Saha SaurabhChief Executive Officer221,017Jul 21, 20250
Chao David MChief Administrative Officer225,007Mar 19, 20250
Rotman HarrisSVP Regulatory Affairs62,625Feb 2, 20240
Grainger David JChief Innovation Officer962,790Jan 2, 20240
GAP (Bermuda) L.P.Director, 10% Owner–Jun 26, 20230
General Atlantic Genpar (Bermuda), L.P.Director, 10% Owner–Jun 26, 20230
General Atlantic Partners (Bermuda) EU, L.P.Director, 10% Owner–Jun 26, 20230
General Atlantic Partners (Bermuda) IV, L.P.Director, 10% Owner–Jun 26, 20230
General Atlantic Partners (Lux), SCSpDirector, 10% Owner–Jun 26, 20230
General Atlantic GenPar (Lux) SCSpDirector, 10% Owner–Jun 26, 20230
General Atlantic (Lux) S.a r.l.Director, 10% Owner–Jun 26, 20230
General Atlantic UM B.V.Director, 10% Owner–Jun 26, 20230
General Atlantic Cooperatief U.A.Director, 10% Owner–Jun 26, 20230
General Atlantic Cooperatief, L.P.Director, 10% Owner–Jun 26, 20230
Yver AntoineEVP & Chairman of Development783,066Jun 2, 20230
Templeman ThomasChief Technology Officer188,244Apr 4, 20230
Shahidi JavadChief Medical Officer165,000Nov 23, 20220
Thorell MarellaChief Accounting Officer53,101Mar 23, 20220
Kantoff AaronDirector60,000Nov 18, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 24, 2026 (view filing)4:23 PM ETJun 24Same dayIndex Ventures Life VI (Jersey) L.P. and 2 others10% OwnerSSale−9.96M––−100.0%0 after2 lots
Jun 24, 2026 (view filing)4:26 PM ETJun 24Same dayMedicxi Growth I LP and 9 others10% OwnerSSale−20.0M––−100.0%0 after6 lots